- 1) NIH publication, Third report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults. National cholesterol education program, no. 01-3670 (2001).
- 2) Ferdinand, K. C., The importance of aggressive lipid management in patients at risk: evidence from recent clinical trials. Clin. Cardiol., 27, 12–15 (2004).
- 3) Bittner, V., Perspectives on dyslipidemia and coronary heart disease in women. J. Am. Coll. Cardiol., 46, 1628–1635 (2005).
- 4) Illingworth, D. R., and Bacon, S., Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia. Am. J. Cardiol., 60, 33G–42G (1987).
- 5) Kramer, W., and Glombik, H., Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs. Curr. Med. Chem., 13, 997–1016 (2006).
- 6) Auger, C., Teissedre, P. L., Gérain, P., Lequeux, N., Bornet, A., Serisier, S., Besançon, P., Caporiccio, B., Cristol, J. P., and Rouanet, J. M., Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. J. Agric. Food Chem., 53, 2015–2021 (2005).
- 7) Torres, N., Torre-Villalvazo, I., and Tovar, A. R., Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders. J. Nutr. Biochem., 17, 365–373 (2006).
- 8) Matsumoto, K., Watanabe, Y., and Yokoyama, S., Okara, soybean residue, prevents obesity in a diet-induced murine obesity model. Biosci. Biotechnol. Biochem., 71, 720–727 (2007).
- 9) Martins, J. M., Riottot, M., de Abreu, M. C., Viegas-Crespo, A. M., Lança, M. J., Almeida, J. A., Freire, J. B., and Bento, O. P., Cholesterol-lowering effects of dietary blue lupin (Lupinus angustifolius L.) in intact and ileorectal anastomosed pigs. J. Lipid Res., 46, 1539–1547 (2005).
- 10) Matsushima, Y., Hayashi, S., and Tachibana, M., Spontaneously hyperlipidemic (SHL) mice: Japanese wild mice with apolipoprotein E deficiency. Mamm. Genome, 10, 352–357 (1999).
- 11) Meir, K. S., and Leitersdorf, E., Atherosclerosis in the apolipoprotein E-deficient mouse: a decade of progress. Arterioscler. Thromb. Vasc. Biol., 24, 1006–1014 (2004).
- 12) Matsushima, Y., Sakurai, T., Ohoka, A., Ohnuki, T., Tada, N., Asoh, Y., and Tachibana, M., Four strains of spontaneously hyperlipidemic (SHL) mice: phenotypic distinctions determined by genetic backgrounds. J. Atheroscler. Thromb., 8, 71–79 (2001).
- 13) Gorinstein, S., Bartnikowska, E., Kulasek, G., Zemser, M., and Trakhtenberg, S., Dietary persimmon improves lipid metabolism in rats fed diets containing cholesterol. J. Nutr., 128, 2023–2027 (1998).
- 14) Lee, J. S., Lee, M. K., Ha, T. Y., Bok, S. H., Park, H. M., Jeong, K. S., Woo, M. N., Do, G. M., Yeo, J. Y., and Choi, M. S., Supplementation of whole persimmon leaf improves lipid profiles and suppresses body weight gain in rats fed high-fat diet. Food Chem. Toxicol., 44, 1875–1883 (2006).
- 15) Matsumoto, K., Watanabe, Y., Ohya, M. A., and Yokoyama, S., Young persimmon fruits prevent the rise in plasma lipids in a diet-induced murine obesity model. Biol. Pharm. Bull., 29, 2532–2535 (2006).
- 16) Bligh, E. G., and Dyer, W. J., A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol., 37, 911–917 (1959).
- 17) Usui, S., Hara, Y., Hosaki, S., and Okazaki, M., A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J. Lipid Res., 43, 805–814 (2002).
- 18) Matsumoto, K., Hiraiwa, N., Yoshiki, A., Ohnishi, M., and Kusakabe, M., PDGF receptor-alpha deficiency in glomerular mesangial cells of tenascin-C knockout mice. Biochem. Biophys. Res. Commun., 290, 1220–1227 (2002).
- 19) den Boer, M., Voshol, P. J., Kuipers, F., Havekes, L. M., and Romijn, J. A., Hepatic steatosis: a mediator of the metabolic syndrome: lessons from animal models. Arterioscler. Thromb. Vasc. Biol., 24, 644–649 (2004).
- 20) Davis, R. A., Miyake, J. H., Hui, T. Y., and Spann, N. J., Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP. J. Lipid Res., 43, 533–543 (2002).
- 21) Kobayashi, M., Ikegami, H., Fujisawa, T., Nojima, K., Kawabata, Y., Noso, S., Babaya, N., Itoi-Babaya, M., Yamaji, K., Hiromine, Y., Shibata, M., and Ogihara, T., Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin. Diabetes, 56, 239–247 (2007).
- 22) Root, C., Smith, C. D., Sundseth, S. S., Pink, H. M., Wilson, J. G., and Lewis, M. C., Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94. J. Lipid Res., 43, 1320–1330 (2002).
- 23) Houten, S. M., Watanabe, M., and Auwerx, J., New EMBO member’s review endocrine functions of bile acids. EMBO J., 25, 1419–1425 (2006).
- 24) Horton, J. D., Shimomura, I., Brown, M. S., Hammer, R. E., Goldstein, J. L., and Shimano, H., Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J. Clin. Invest., 101, 2331–2339 (1998).
- 25) Amemiya-Kudo, M., Shimano, H., Hasty, A. H., Yahagi, N., Yoshikawa, T., Matsuzaka, T., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., Osuga, J., Harada, K., Gotoda, T., Sato, R., Kimura, S., Ishibashi, S., and Yamada, N., Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. J. Lipid Res., 43, 1220–1235 (2002).
- 26) Gälman, C., Ostlund-Lindqvist, A. M., Björquist, A., Schreyer, S., Svensson, L., Angelin, B., and Rudling, M., Pharmacological interference with intestinal bile acid transport reduces plasma cholesterol in LDL receptor/apoE deficiency. FASEB J., 17, 265–267 (2003).
- 27) Zelcer, N., and Tontonoz, P., Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest., 116, 607–613 (2006).
- 28) Miao, B., Zondlo, S., Gibbs, S., Cromley, D., Hosagrahara, V. P., Kirchgessner, T. G., Billheimer, J., and Mukherjee, R., Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. J. Lipid Res., 45, 1410–1417 (2004).
- 29) Postic, C., and Girard, J., Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest., 118, 829–838 (2008).
- 30) Grefhorst, A., Elzinga, B. M., Voshol, P. J., Plösch, T., Kok, T., Bloks, V. W., van der Sluijs, F. H., Havekes, L. M., Romijn, J. A., Verkade, H. J., and Kuipers, F., Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J. Biol. Chem., 277, 34182–34190 (2002).
Full access
Hypolipidemic Effect of Young Persimmon Fruit in C57BL/6.KOR-ApoEshl Mice
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.